Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion type Assertion NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_head.
- NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_provenance.
- NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion evidence source_evidence_literature NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_provenance.
- NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion SIO_000772 14597629 NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_provenance.
- NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion wasDerivedFrom befree-2016 NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_provenance.
- NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion wasGeneratedBy ECO_0000203 NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_provenance.